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Membrane lipids may potentially be involved in cell growth
control. The fatty acid composition of membrane phos-
pholipids is an important component of the regulatory
apparatus for membrane structure and function (Stubbs &
Smith, 1984; Spector & Yorek, 1985), including growth fac-
tor receptor properties (Ginsberg et al., 1981). Changes in
lipid composition may alter pathways involved in membrane
transduction of external signals and may consequently
modulate the response of tumour cells to growth factors,
thereby modifying the evolution of cancer (Spector & Burns,
1987).
We report the preliminary data of a prospective study
where the fatty acid composition of membrane phospholipids
of breast carcinoma was analysed in order to examine if
alterations in the membrane lipid composition of the car-
cinoma is associated with a specific behaviour of the tumour,
namely the occurrence of metastasis.
Tumour tissue specimens were obtained from 32 previously
untreated patients. They had a localised presentation of
invasive breast carcinoma (Table I), according to standar-
dised rules of staging (Harris et al., 1985). No visceral meta-
stasis was detected at the time of surgery, the first therapeutic
step. Treatment also included radiation therapy, adjuvant
chemotherapy and hormonotherapy wherever appropriated.
Follow-up was carried out every 4 months in the first year,
then every 6 months. Investigations were performed when
indicated, in order to assess unambiguously the presence of
systemic metastasis. At the time of analysis, metastasis had
occurred in eight patients within 1-24 months (Table I).
Time to follow-up was 6-41 months for patients who have
not yet developed metastasis.
After excision of all visible fat tissue, samples were washed
in saline and immediately frozen in liquid nitrogen. At the
time of processing, tumour samples were pulverized in liquid
nitrogen and homogenized (Ultra-Turrax) at 4°C in a 0.15 M
phosphate buffer pH 7.4. After centrifugation (60,000 g, 1 h)
at 4'C, the upper layer, including the floating fat, was dis-
carded. Lipids were analysed as previously described (Boug-
noux et al., 1985). In brief, lipids were extracted from the
membrane-enriched pellet, separated into classes by two-
dimensional TLC, and fatty acids were transmethylated and
analysed by capillary gas chromatography.
The fatty acid composition of phosphatidylethanolamine
(PE), a major phospholipid class, is shown in Table II. The
sum of linoleic and arachidonic acids (further referred to as
n-6 PUFA) ranged from 11.6 to 58.4% of total fatty acids.
As shown in Figure 1, the n-6 PUFA content was lower in
tumours that gave rise to systemic metastasis (eight patients),
than in tumours that did not (24 patients) (P<0.01, Wilcox-
on's sum of ranks test).
The predictive value of the n-6 PUFA content of PE on
metastasis occurrence was examined. For this purpose, a
cut-off level was set up at 28% of total fatty acids. This value
was derived from a preliminary analysis of the data obtained
with the first 12 patients. It was chosen as the highest n-6
PUFA content of tumour PE observed among the four
patients who had developed metastasis at the time, and was
used prospectively for the subsequent analysis. The prob-
ability of remaining metastasis-free is presented in Figure 2,
and the difference between the two curves was statistically
significant (P<0.02, log rank test). For instance, at 18
months, the probability of remaining metastasis-free was
67% (95% CI 45-89%) when the n-6 PUFA content was
below the threshold, with 12 patients still on study. When the
n-6 PUFA content was above the threshold, the probability
of remaining metastasis-free at 18 months was 100%, with 10
patients still on study.
When adjusted for the lymph-node status (0 vs 1 or more
positive axillary lymph-nodes), the tumour size (< 30 vs
> 30 mm), and the histoprognostic grade (Bloom & Richard-
son, 1957) (1 or 2 vs 3), the level of n-6 PUFA taken as a
continuous variable remained linked with the risk of metas-
tasis occurrence (P = 0.004, likelihood ratio test, Cox's pro-
portional hazard model) (Cox, 1972).
This study indicates that in breast cancer, a level of n-6
PUFA lower than 28% of total fatty acids in membrane PE
of the tumour is associated with a high probability of early
occurrence of metastasis independently of the tumour size, of
the existence of an axillary lymph-node invasion and of the
histological grade of the tumour.
Identification of the mechanisms that may be responsible
for the differences in membrane fatty acid composition
between patients with a high or low probability of relapse
remains a central issue. Differences in membrane lipid com-
position can be understood as a consequence of a change in
the activity or specificity of enzymes which control lipid
metabolism, and fatty acid turnover and release. Such
changes can be the consequence of genomic alterations
acquired during the tumour progression (Nowell, 1986).
Besides specific tumour membrane lipids metabolism,
dietary fatty acids are known to influence the fatty acid
composition of storage and membrane lipids, both in normal
and carcinoma tissues, and also to influence the development
of mammary tumours in several experimental systems (Tins-
ley, 1989). Few studies have examined the influence of
dietary fat on the metastatic evolution of tumours. The
growth of pulmonary metastasis from a transplantable mam-
mary tumour was enhanced by a high fat diet rich in omega-
6 fatty acids (Katz & Boylan, 1987; Hubbard & Erickson,
1987), under experimental conditions where the linoleate con-
tent of the transplanted tumour was increased (Hubbard &
Erickson, 1987). These animal studies do not corroborate our
results since we found a low level of PUFA content to be
associated with an aggressive tumour behaviour. The reasons
for this discrepancy are presently unknown. No dietary re-
calls are available for our patients. However, a selection of
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Table I Clinical features of patients
Carcinoma
Menopausal Lymph-nodes Site offirst Current
No. Age status BMP Typeb Grading' Tumour sized (LIE)e metastasis status
1 47 18 D 2 7 2/11 Bones
2 46 23 D 3 16 0/18
3 38 - 29 D 3 40 2/8 Lung Dead
4 60 + 22 D 2 25 0/12
5 65 + 22 L 2 6 0/12
6 64 + 31 D 2 25 0/16
7 50 - D 2 20 1/7
8 48 23 D 3 20 0/9
9 27 - 20 D 3 - 17/20 Lung Dead
10 63 + 20 D 3 20 8/20
11 47 - 16 D 2 10 0/25
12 42 23 D 2 30 15/25 Lung Dead
13 64 + 20 D 2 15 0/24
14 61 + 33 D 3 11 0/11 Dead
15 45 23 D 2 25 1/11
16 58 + 18 D 3 22 2/5 Skin Dead
17 66 + 25 D 2 10 3/14
18 38 - 22 D 2 20 0/21
19 47 - 24 D 2 40 19/21
20 54 + 27 D 3 20 0/13 Bones Dead
21 43 21 D 2 20 0/15
22 69 + 22 D 3 22 20/23 Bones
23 61 + 26 D 2 16 0/15
24 54 - 25 D 2 20 0
25 60 + 34 D 2 15 0/18
26 73 + 23 D 2 - 11/11 Bones
27 40 - 22 U 2 35 4/17
28 49 - 18 D 3 30 2/11
29 43 - 19 L 2 20 3/19
30 39 - 19 U 2 20 1/11
31 51 + 24 D 2 15 3/8
32 77 + 27 D 3 10 1/15
aBody mass index (W/H2). bD, invasive ductal carcinoma; L, invasive lobular carcinoma; U, invasive
carcinoma of uncertain type. cGrading according to Bloom & Richardson (1957). clmm, minimal size
measured on the carcinoma during pathological examination. 'Number of positive (L)
lymph-nodes/examined (E) lymph-nodes.
Table II Fatty acid composition of breast tumour
phosphatidylethanolamine
Phosphatidylethanolamine
Fatty acids Mean (%)a Range (%)
Saturated
16:0b 5.8 1.2-10.4
18:0 18.7 9.9-33.3
Unsaturated
16:1 w7 1.4 0.1-5.9
18: c 23.5 12.0-39.9
18:2 w6 9.3 2.8-16.6
20:206 0.4 0.1-5.2
20:3 w6 2.1 0.4-9.6
20:4w6 20.1 8.8-43.7
22:6 W3 3.5 0.3-6.8
DMAd 5.7 0.1-15.4
aExpressed as % oftotal area; variation amongmeasureswas lessthan
2%;nonidentifiedfattyacidsaccountedforlessthan4.8%.bDenotedas
number ofcarbons: number ofdouble bonds. CExpressed as the sum of
18:1 w7 + 18:1 w9. dDimethyl acetals of fatty aldehydes.
patients with very different specific dietary habits among a
group with an identical culture and living in the same area
seems unlikely. In any case, the modalities of tumour speci-
mens collection used in the present study could not have
allowed such a selection.
No data relating dietary fat to tumour membrane fatty
acid composition are available in humans. However,
epidemiological studies suggest that the quantity and the
quality of dietary fat intake are associated with differences in
post-treatment survival rates (Wynder et al., 1986; Gregorio
et al., 1985). Another study found an effect of body weight,
but not of dietary fat, on survival (Newman et al., 1986). A
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Figure 1 Distribution of patients by their intra-tumour mem-
brane level of n-6 polyunsaturated fatty acids in phosphati-
dylethanolamine. Hatched frames represent patients without
relapses and closed frames patients in whom metastases occurred
during the follow-up period. Lipids were prepared from the
primary tumor and separated in phospholipid classes as described
in methods. Fatty acids composition of phos-
phatidylethanolamine (PE) was determined by gas chromatog-
raphy. n-6 PUFA refers to the sum of linoleic and arachidonic
acids, expressed as % of the total fatty acid content of PE.
relationship was recently reported between dietary intake of
polyunsaturated fatty acids before diagnosis and the lack of
axillary lymph node extension of tumours (Verreault et al.,
1988), a clinical situation associated with a lower probability
of subsequent metastasis. It is therefore possible that the
quality of dietary fat influences not only tumour incidence,
but also breast cancer presentation.778 M. LANSON et al.
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Figure 2 Probability of remaining metastasis-free according to
the n-6 PUFA contents of tumour phosphatidylethanolamine.
Continuous line and dashed line represent patients with levels of
n-6 PUFA respectively above or below 28% of total fatty acids.
Proportion of N + patients: 8/14 and 10/18. x2 = 6.21, P<0.02.
Presently, the clinical management of breast cancer
patients relies on each patient's individual risk factors
(McGuire, 1989). The low level of n-6 PUFA in the primary
tumour appears to be a predictor of subsequent metastasis,
although its independence from other prognostic factors
should be thoroughly evaluated in an expanded study.
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